Cellular glutathione in fatty liver in vitro models - PubMed (original) (raw)
Cellular glutathione in fatty liver in vitro models
Martha C Garcia et al. Toxicol In Vitro. 2011 Oct.
Abstract
The range of non-alcoholic fatty liver disease (NAFLD) includes simple hepatic steatosis, the inflammatory non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. The accumulation of specific lipids in hepatocytes has been associated with oxidative stress and progression of the disease. Elevated serum free fatty acids and hepatocyte lipotoxicity can be studied in an in vitro cellular model. For this purpose, we cultured the human liver cell line, HepG2/C3A, in medium supplemented with increasing amounts of oleic acid (C18:1) and evaluated oxidative stress by measuring the content of the cellular antioxidant, glutathione (GSH). We observed a dose-dependent steatosis, as determined by Nile Red staining, with concurrent increases of GSH; similar findings were also observed in cultured human hepatocytes. Cells cultured with palmitic acid (C16:0) or the combination oleic/palmitic acids (2:1 ratio) also exhibited a dose-dependent increase of GSH; however palmitic-supplemented cultures did not sustain the GSH increase after 24h. We also detected an increase in the formation of lipid peroxides (LPO) indicating that the increase of GSH was a cellular mechanism that may be related to the high exposure of fatty acids. The results of this in vitro study suggest an antioxidant response against fat overloading and indicate potential differences in response to specific fatty acid-induced hepatic steatosis and associated lipotoxicity.
Published by Elsevier Ltd.
Similar articles
- Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni S, Lonardo A, Carulli N, Loria P. Ricchi M, et al. J Gastroenterol Hepatol. 2009 May;24(5):830-40. doi: 10.1111/j.1440-1746.2008.05733.x. Epub 2009 Jan 13. J Gastroenterol Hepatol. 2009. PMID: 19207680 - A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV, O'Connor JE. Gómez-Lechón MJ, et al. Chem Biol Interact. 2007 Jan 30;165(2):106-16. doi: 10.1016/j.cbi.2006.11.004. Epub 2006 Nov 23. Chem Biol Interact. 2007. PMID: 17188672 - Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
Vesterdal LK, Danielsen PH, Folkmann JK, Jespersen LF, Aguilar-Pelaez K, Roursgaard M, Loft S, Møller P. Vesterdal LK, et al. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):350-60. doi: 10.1016/j.taap.2013.10.001. Epub 2013 Oct 11. Toxicol Appl Pharmacol. 2014. PMID: 24121055 - Mitochondrial glutathione: hepatocellular survival-death switch.
Garcia-Ruiz C, Fernandez-Checa JC. Garcia-Ruiz C, et al. J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S3-6. doi: 10.1111/j.1440-1746.2006.04570.x. J Gastroenterol Hepatol. 2006. PMID: 16958667 Review. - Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J, Choi SS, Diehl AM. Jou J, et al. Semin Liver Dis. 2008 Nov;28(4):370-9. doi: 10.1055/s-0028-1091981. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956293 Review.
Cited by
- Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.
Willebrords J, Pereira IV, Maes M, Crespo Yanguas S, Colle I, Van Den Bossche B, Da Silva TC, de Oliveira CP, Andraus W, Alves VA, Cogliati B, Vinken M. Willebrords J, et al. Prog Lipid Res. 2015 Jul;59:106-25. doi: 10.1016/j.plipres.2015.05.002. Epub 2015 Jun 11. Prog Lipid Res. 2015. PMID: 26073454 Free PMC article. Review. - CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation.
Gao H, Cao Y, Xia H, Zhu X, Jin Y. Gao H, et al. Int J Mol Med. 2020 Apr;45(4):1121-1129. doi: 10.3892/ijmm.2020.4479. Epub 2020 Jan 28. Int J Mol Med. 2020. PMID: 32124935 Free PMC article. - Differential effects of bariatric surgery and caloric restriction on hepatic one-carbon and fatty acid metabolism.
Haran A, Bergel M, Kleiman D, Hefetz L, Israeli H, Weksler-Zangen S, Agranovich B, Abramovich I, Ben-Haroush Schyr R, Gottlieb E, Ben-Zvi D. Haran A, et al. iScience. 2023 Jun 7;26(7):107046. doi: 10.1016/j.isci.2023.107046. eCollection 2023 Jul 21. iScience. 2023. PMID: 37389181 Free PMC article. - Beneficial Effects of Standardized Extracts from Wastes of Red Oranges and Olive Leaves.
Burò I, Consoli V, Castellano A, Vanella L, Sorrenti V. Burò I, et al. Antioxidants (Basel). 2022 Jul 30;11(8):1496. doi: 10.3390/antiox11081496. Antioxidants (Basel). 2022. PMID: 36009215 Free PMC article. - Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model.
Hefer M, Petrovic A, Roguljic LK, Kolaric TO, Kizivat T, Wu CH, Tabll AA, Smolic R, Vcev A, Smolic M. Hefer M, et al. Curr Issues Mol Biol. 2024 Aug 16;46(8):8981-8994. doi: 10.3390/cimb46080531. Curr Issues Mol Biol. 2024. PMID: 39194748 Free PMC article.